Detalhe da pesquisa
1.
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.
Int J Cancer
; 145(7): 1935-1945, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860598
2.
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599028
3.
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.
Front Immunol
; 8: 533, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28572802
4.
A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma.
Front Immunol
; 8: 676, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28659917
5.
Immune imbalance in nasal polyps of Caucasian chronic rhinosinusitis patients is associated with a downregulation of E-selectin.
J Immunol Res
; 2014: 959854, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24995349